Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. O'Brien, M. Feingold (1985)
Incontinentia pigmenti. A longitudinal study.American journal of diseases of children, 139 7
D. Wiklund, W. Weston (1980)
Incontinentia pigmenti. A four-generation study.Archives of dermatology, 116 6
Y. Chan, Giam Yc (2001)
A retrospective study of incontinentia pigmenti seen at the National Skin Centre, Singapore over a 10-year period.Annals of the Academy of Medicine, Singapore, 30 4
R. Happle (2003)
A fresh look at incontinentia pigmenti.Archives of dermatology, 139 9
A. Ormerod, M. White, E. McKay, A. Johnston (1987)
Incontinentia pigmenti in a boy with Klinefelter's syndrome.Journal of Medical Genetics, 24
S. Aradhya, G. Courtois, Aleks Rajkovic, Richard Lewis, Moise Levy, A. Israël, David Nelson (2001)
Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma).American journal of human genetics, 68 3
S. Hennel, P. Ekert, J. Volpe, T. Inder (2003)
Insights into the pathogenesis of cerebral lesions in incontinentia pigmenti.Pediatric neurology, 29 2
R. Carney (1976)
Incontinentia pigmenti. A world statistical analysis.Archives of dermatology, 112 4
C. Moss, P. Ince (1987)
Anhidrotic and achromians lesions in incontinentia pigmentiBritish Journal of Dermatology, 116
A. Berlin, A. Paller, L. Chan (2002)
Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology.Journal of the American Academy of Dermatology, 47 2
T. Basarab, M. Dunnill, S. Munn, R. Russell‐Jones (1998)
Incontinentia pigmenti: variable disease expression within an affected familyJournal of the European Academy of Dermatology and Venereology, 11
S. Aradhya, H. Woffendin, T. Jakins, T. Bardaro, T. Esposito, A. Smahi, C. Shaw, M. Levy, A. Munnich, M. D'urso, R. Lewis, S. Kenwrick, D. Nelson (2001)
A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations.Human molecular genetics, 10 19
J. Kunze, Ulrich Frenzel, E. Hüttig, F. Grosse, H. Wiedemann (1977)
Klinefelter's syndrome and incontinentia pigmenti Bloch-SulzbergerHuman Genetics, 35
Asmae Smahl, G. Courtols, Pierre Vabres, S. Yamaoka, S. Heuertz, A. Munnich, A. Israël, Nina Helss, S. Klauck, P. Kloschls, S. Wiemann, A. Poustka, Teresa Esposlto, T. Bardaroll, F. Gianfrancesco, A. Ciccodicola, M. D'urso, Hayley Woffendln, T. Jaklns, D. Donnal, H. Stewart, S. Kenwrick, S. Aradhya, T. Yamagata, M. Levy, R. Lewis, D. Nelson (2000)
Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmentiNature, 405
J. Garcia-Dorado, P. Unamuno, E. Fernández‐López, J. Veloz, M. Armijo (1990)
Incontinentia pigmenti: XXY male with a family historyClinical Genetics, 38
Heathcote Jg, S. Ba, Willis Nr (1991)
Incontinentia pigmenti (Bloch-Sulzberger syndrome): a case report and review of the ocular pathological features.Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 26 4
Andrew Lee, M. Goldberg, J. Gillard, P. Barker, R. Bryan (1995)
Intracranial assessment of incontinentia pigmenti using magnetic resonance imaging, angiography, and spectroscopic imaging.Archives of pediatrics & adolescent medicine, 149 5
N. Bodak, S. Hadj-Rabia, D. Hamel-Teillac, Y. Prost, C. Bodemer (2003)
Late recurrence of inflammatory first-stage lesions in incontinentia pigmenti: an unusual phenomenon and a fascinating pathologic mechanism.Archives of dermatology, 139 2
A. Smahi, G. Courtois, Pierre Vabres, S. Yamaoka, S. Heuertz, A. Munnich, A. Israël, N. Heiss, S. Klauck, P. Kioschis, S. Wiemann, A. Poustka, T. Esposito, T. Bardaro, F. Gianfrancesco, A. Ciccodicola, M. D'urso, H. Woffendin, T. Jakins, D. Donnai, H. Stewart, S. Kenwrick, S. Aradhya, T. Yamagata, M. Levy, R. Lewis, D. Nelson (2000)
Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.Nature, 405 6785
A. Spallone (1987)
Incontinentia pigmenti (Bloch-Sulzberger syndrome): seven case reports from one family.British Journal of Ophthalmology, 71
JS Francis, VP Sybert (1997)
Incontinentia pigmenti, 16
C. Cates, S. Dandekar, D. Flanagan, A. Moore (2003)
Retinopathy of incontinentia pigmenti: a case report with thirteen years follow-upOphthalmic Genetics, 24
S. Hadj-Rabia, David Froidevaux, N. Bodak, D. Hamel-Teillac, A. Smahi, Y. Touil, S. Fraitag, Y. Prost, C. Bodemer (2003)
Clinical study of 40 cases of incontinentia pigmenti.Archives of dermatology, 139 9
C. Moss (1999)
Cytogenetic and molecular evidence for cutaneous mosaicism: the ectodermal origin of Blaschko lines.American journal of medical genetics, 85 4
H. Hamm (1999)
Cutaneous mosaicism of lethal mutations.American journal of medical genetics, 85 4
J. Lamartine (2003)
Towards a new classification of ectodermal dysplasiasClinical and Experimental Dermatology, 28
SJ Landy, D Donnai (1993)
Incontinentia pigmenti (Bloch–Sulzberger syndrome), 30
R. Leeuwen, M. Wintzen, M. Praag (2000)
Incontinentia Pigmenti: An Extensive Second Episode of a “First‐Stage” Vesicobullous EruptionPediatric Dermatology, 17
V. Nazzaro, A. Brusasco, C. Gelmetti, E. Ermacora, R. Caputo (1990)
Hypochromic Reticulated Streaks in Incontinentia Pigmenti: An Immunohistochemical and Ultrastructural StudyPediatric Dermatology, 7
P. Dutheil, Pierre Vabres, M. Cayla, O. Enjolras (1995)
Incontinentia Pigmenti: Late Sequelae and Genotypic Diagnosis: A Three‐Generation Study of Four PatientsPediatric Dermatology, 12
Summary A retrospective case series of 53 female patients with incontinentia pigmenti (IP) including 28 secondary cases (female relatives of probands) was reviewed and compared with other series in an attempt to estimate more accurately the true disease burden of patients with IP. We found that, while the frequency of the first three cutaneous stages of IP was comparable with previous studies, none of the secondary cases manifested any serious neurological complications but all displayed stage IV pale anhidrotic reticulate lines on their posterior calves. This important clinical feature of IP in secondary cases has previously been under‐represented in studies that often involved only paediatric probands. Hence, mildly affected cases of IP are often undiagnosed and under‐represented in case series to date, possibly leading to inappropriately high estimates of neurological and eye involvement. With the availability of genetic testing, it is now feasible to confirm the variability of the phenotype and the risk of complications in IP.
Clinical & Experimental Dermatology – Wiley
Published: Sep 1, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.